Literature DB >> 16506641

Noncardiac surgery and the risk of death and other cardiovascular events in patients with hypertrophic cardiomyopathy.

Haitham Hreybe1, Malma Zahid, Ali Sonel, Chester B Good, James Shaver, Samir Saba.   

Abstract

BACKGROUND: There is a paucity of reports evaluating the perioperative risk of noncardiac surgery in patients with hypertrophic cardiomyopathy (HCM). HYPOTHESIS: The study was undertaken to evaluate the incidence of acute myocardial infarction (MI) and all-cause inhospital mortality following noncardiac surgery in patients with HCM.
METHODS: We searched the National Hospital Discharge Survey database for patients with a diagnosis of HCM who had undergone noncardiac surgery. Cases were matched by age, gender, and year of surgery. Death or acute MI were used as endpoints for analysis.
RESULTS: From 1996 to 2002, 227 patients with HCM were matched with 554 controls (representing national estimates of 25,874 HCM and 50,326 controls patients). Patients with HCM were more likely than controls to have a history of atrial fibrillation (22.7 vs. 10.6%, p < 0.001) and of congestive heart failure (CHF) (24.2 vs. 14.1%, p < 0.001). The in-hospital incidence of death or MI was higher in patients with HCM than in controls (6.7 vs. 2.5%, p < 0.001 for death and 2.2 vs. 0.3%, p < 0.001 for MI). After correcting for age, gender, race, presence of hypertension, diabetes mellitus, history of coronary artery-disease, history of CHF, atrial fibrillation, and ventricular arrhythmias in a multivariate binary logistic regression model, the presence of HCM increased the odds of death by 61% (odds ratio [OR] = 1.61, 95% confidence interval [CI] 1.46-1.77, p < 0.001), and almost tripled the odds of the combined endpoint of death or MI (OR = 2.82, 95% CI 2.59-3.07, p < 0.001).
CONCLUSION: The presence of HCM significantly increases the risk of death and MI associated with noncardiac surgery. Patients with HCM undergoing elective procedures may require more careful preoperative assessment and perioperative monitoring. The impact of the severity of HCM on outcomes of noncardiac surgery needs further study.

Entities:  

Mesh:

Year:  2006        PMID: 16506641      PMCID: PMC6653848          DOI: 10.1002/clc.4960290206

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  10 in total

1.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Authors:  Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

2.  Role of genotyping in risk factor assessment for sudden death in hypertrophic cardiomyopathy.

Authors:  William J McKenna; Jens Mogensen; Perry M Elliott
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

3.  [Perioperative cardiovascular complications in patients with hypertrophic cardiomyopathy].

Authors:  Masayuki Kuroiwa; Masayasu Arai; Tetsuo Ueno; Tomoaki Takenaka; Hirotsugu Okamoto; Sumio Hoka
Journal:  Masui       Date:  2003-07

Review 4.  Clinical practice. Hypertrophic obstructive cardiomyopathy.

Authors:  Rick A Nishimura; David R Holmes
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

Review 5.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

6.  Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy.

Authors:  J M Haering; M E Comunale; R A Parker; E Lowenstein; P S Douglas; H M Krumholz; W J Manning
Journal:  Anesthesiology       Date:  1996-08       Impact factor: 7.892

7.  Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients.

Authors:  L Fananapazir; C M Tracy; M B Leon; J B Winkler; R O Cannon; R O Bonow; B J Maron; S E Epstein
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

Review 8.  [Anesthetic management of patients with hypertrophic obstructive cardiomyopathy undergoing non-cardiac surgery].

Authors:  Kyung-Ho Chang; Erika Sano; Yuichiro Saitoh; Kazuo Hanaoka
Journal:  Masui       Date:  2004-08

Review 9.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

Authors:  Barry J Maron; Bernard R Chaitman; Michael J Ackerman; Antonio Bayés de Luna; Domenico Corrado; Jane E Crosson; Barbara J Deal; David J Driscoll; N A Mark Estes; Claudio Gil S Araújo; David H Liang; Matthew J Mitten; Robert J Myerburg; Antonio Pelliccia; Paul D Thompson; Jeffrey A Towbin; Steven P Van Camp
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

10.  Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.

Authors:  L Fananapazir; A C Chang; S E Epstein; D McAreavey
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

  10 in total
  5 in total

Review 1.  Society for Translational Medicine Expert Consensus on the preoperative assessment of circulatory and cardiac functions and criteria for the assessment of risk factors in patients with lung cancer.

Authors:  Deruo Liu; Huanshun Wen; Jie He; Shugeng Gao; Shanqing Li; Lunxu Liu; Jianxing He; Yunchao Huang; Shidong Xu; Weimin Mao; Qunyou Tan; Chun Chen; Xiaofei Li; Zhu Zhang; Gening Jiang; Lin Xu; Lanjun Zhang; Jianhua Fu; Hui Li; Qun Wang; Lijie Tan; Danqing Li; Qinghua Zhou; Xiangning Fu; Zhongmin Jiang; Haiquan Chen; Wentao Fang; Xun Zhang; Yin Li; Ti Tong; Zhentao Yu; Yongyu Liu; Xiuyi Zhi; Tiansheng Yan; Xingyi Zhang; Alessandro Brunelli; Michele Salati; Kevin Phan; Yasuhiro Hida; Federico Venuta; Jin-Ho Choi; Kostas Papagiannopoulos; Duc Ha; Nuria Novoa
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Routinely collected health data to study inherited heart disease: a systematic review (2000-2016).

Authors:  Bianca Blanch; Joanna Sweeting; Christopher Semsarian; Jodie Ingles
Journal:  Open Heart       Date:  2017-10-11

3.  Outcomes following general anaesthesia in children with hypertrophic cardiomyopathy.

Authors:  Gabrielle Norrish; Natalie Forshaw; Colleen Woo; Mary Claire Avanis; Ella Field; Elena Cervi; Akane Iguchi; Juan Pablo Kaski
Journal:  Arch Dis Child       Date:  2018-11-09       Impact factor: 3.791

Review 4.  The Preoperative Patient With a Systolic Murmur.

Authors:  Brian Cowie
Journal:  Anesth Pain Med       Date:  2015-12-05

5.  Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Yoichi Imori; Hitoshi Takano; Hiroshi Mase; Junya Matsuda; Hideto Sangen; Yuki Izumi; Yukichi Tokita; Takeshi Yamamoto; Wataru Shimizu
Journal:  BMC Cardiovasc Disord       Date:  2019-12-30       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.